Prevalence of non-HLA antibodies and their association with FIB-4 index-based fibrosis risk in pediatric liver transplant recipients with long-term graft survival (>10 years).

Front Immunol · 2026 · PMC13310716 · PMID 42375352

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep=0.07so close (0.05 < p ≤ 0.1)

Patients positive for anti-IFNG antibodies also showed higher FIB-4 values, although differences did not reach statistical significance ( Figure 5B ; 7.71 IQR [4.79–13.38] vs. 3.12 IQR [0.94–5.36], p=0.07).

also in 111,027 other papers

showed a trendp=0.08so close (0.05 < p ≤ 0.1)

In contrast, anti-GDNF antibody positivity showed a trend toward an increased risk of elevated FIB-4 index in the univariate analysis (OR 4.03 [1.00-27.13], p=0.08).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Prevalence of non-HLA antibodies and their association with FIB-4 index-based fibrosis risk in pediatric liver transplant recipients with long-term graft survival (&gt;10 years).

The sentences

Prevalence of non-HLA antibodies and their association with FIB-4 index-based fibrosis risk in pediatric liver transplant recipients with long-term graft survival (>10 years).